Chester County News and Community Website
MALVERN, PA — Endo, Inc. (OTCQX: NDOI) has announced plans to release its fourth quarter and full-year 2024 financial results on March 11, 2025, before the market opens. The company will …
Endo, Inc. to Announce 2024 Financial Results on March 11, 2025 Read More MALVERN, PA — Endo, Inc. (OTCQX: NDOI) has unveiled its new branded television commercial, “Steve’s Journey,” as part of a broader effort to educate the public about Dupuytren’s contracture, a progressive …
Endo, Inc. Launches New “Steve’s Journey” Campaign to Raise Awareness About Dupuytren’s Contracture Read More
EXTON, PA — First Resource Bancorp, Inc. (OTCQX: FRSB), the holding company for First Resource Bank, has announced the appointment of Jim Egan as Senior Vice President of Commercial Lending. Egan, …
First Resource Bancorp Welcomes Jim Egan as SVP of Commercial Lending Read More EXTON, PA — First Resource Bancorp, Inc. (OTCQX: FRSB), the holding company for First Resource Bank, announced its financial results for the year ending December 31, 2024, showcasing strong growth in …
First Resource Bancorp Highlights Growth in Loans and Deposits Amid 2024 Challenges Read More MALVERN, PA — Endo, Inc. (OTCQX: NDOI) has launched its new television commercial and disease awareness campaign, “I Got Somebody,” to encourage men experiencing symptoms of Peyronie’s disease (PD) to take …
Endo, Inc. Launches “I Got Somebody” Campaign to Raise Awareness About Peyronie’s Disease Read More MALVERN, PA — Endo, Inc. (OTCQX: NDOI) has introduced a new tool to support men dealing with Peyronie’s disease (PD). The self-assessment screening app, designed to help individuals identify and …
ICYMI: New App Helps Men Address Peyronie’s Disease Read More MALVERN, PA — Endo, Inc. (OTCQX: NDOI) has introduced a free self-assessment app designed to help men manage Peyronie’s disease (PD), a condition involving penile curvature that can be both …
New App Aims to Empower Men with Peyronie’s Disease Read More MALVERN, PA — Endo, Inc. (OTCQX: NDOI) has announced the start of shipments for its doxycycline for injection, USP 100 mg/vial, a generic alternative to DOXY 100™. This marks a significant …
Endo Inc. Launches Generic Doxycycline for Injection Read More MALVERN, PA — Endo, Inc. (OTCQX: NDOI) has secured U.S. Food and Drug Administration (FDA) approval for the commercial production of VASOSTRICT® (vasopressin injection, USP) at its newly constructed aseptic manufacturing …
Endo Receives FDA Approval for New Sterile Injectable Facility in India Read More MALVERN, PA — Endo, Inc. (OTCQX: NDOI) has introduced the ADRENALIN® ready-to-use premixed intravenous (IV) bag, the first FDA-approved epinephrine premixed bag prepared directly by the manufacturer. This significant development is …
Endo, Inc. Launches FDA-Approved ADRENALIN® Premixed Epinephrine Bag Read More